추천 제품
Grade
certified reference material
pharmaceutical secondary standard
Quality Level
Agency
traceable to BP 629
traceable to Ph. Eur. Y0001080
traceable to USP 1379401
API family
meloxicam
CofA
current certificate can be downloaded
포장
pkg of 500 mg
기술
HPLC: suitable
gas chromatography (GC): suitable
응용 분야
pharmaceutical (small molecule)
형식
neat
저장 온도
2-8°C
InChI
1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,19H,1-2H3,(H,15,16)/b13-11+
InChI key
DWMREKMVXIFPFM-ACCUITESSA-N
유사한 제품을 찾으십니까? 방문 제품 비교 안내
일반 설명
This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Meloxicam is an oxicam derivative and belongs to the group of non-steroidal anti-inflammatory drugs (NSAID), used for its analgesic, anti-inflammatory, and antipyretic properties. It acts by inhibiting the activity of prostaglandin synthetase, thereby preventing the synthesis of prostaglandins and decreasing inflammation.
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Meloxicam is an oxicam derivative and belongs to the group of non-steroidal anti-inflammatory drugs (NSAID), used for its analgesic, anti-inflammatory, and antipyretic properties. It acts by inhibiting the activity of prostaglandin synthetase, thereby preventing the synthesis of prostaglandins and decreasing inflammation.
애플리케이션
This pharmaceutical secondary standard can also be used as follows:
- Development of three spectrophotometric methods to determine meloxicam in its pharmaceutical formulations
- Voltammetric determination of meloxicam in pharmaceutical formulations using a boron-doped diamond electrode (BDDE)
- High-performance liquid chromatography-based quantitative analysis of meloxicam in its different tablet formulations
- Development and validation of a reversed-phase HPLC method for the separation and estimation of meloxicam in its pharmaceutical dosage forms
- Quantification of meloxicam and piroxicam from plasma samples using a liquid chromatography method combined with UV detection
분석 메모
These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
각주
To see an example of a Certificate of Analysis for this material enter LRAB7807 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.
추천 제품
Find a digital Reference Material for this product available on our online platform ChemisTwin® for NMR. You can use this digital equivalent on ChemisTwin® for your sample identity confirmation and compound quantification (with digital external standard). An NMR spectrum of this substance can be viewed and an online comparison against your sample can be performed with a few mouseclicks. Learn more here and start your free trial.
관련 제품
제품 번호
설명
가격
신호어
Danger
유해 및 위험 성명서
Hazard Classifications
Acute Tox. 3 Oral
Storage Class Code
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
WGK
WGK 2
Flash Point (°F)
Not applicable
Flash Point (°C)
Not applicable
가장 최신 버전 중 하나를 선택하세요:
이미 열람한 고객
Reverse phase HPLC method development and validation for determination of Meloxicam in bulk and pharmaceutical formulation
International Journal of Pharmaceutical Sciences and Research, 2, 107-107 (2011)
Electrochemical oxidation of anti-inflammatory drug meloxicam and its determination using boron doped diamond electrode
Journal of Electroanalytical Chemistry, 858, 113758-113758 (2020)
High-performance liquid chromatography determination of meloxicam and piroxicam with ultraviolet detection
Chromatography Research International, 2014 (2014)
Materials science & engineering. C, Materials for biological applications, 118, 111544-111544 (2020-12-02)
This work describes the formulation and evaluation of a chitosan microneedle patch for the transdermal delivery of meloxicam to manage pain in cattle. Microneedle patches composed of chitosan and chitosan/meloxicam were evaluated regarding their chemical composition, uniformity of physical characteristics
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.